Non-Contrast CT Imaging Market. In 2023, the non-contrast CT imaging market is expected to be worth USD 226.5 million. The ...

Inquis Medical, which is developing therapies for venous thromboembolic diseases, announced the completion of patient ...

Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient ...

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...

Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional ...

Risk for venous thromboembolism during pregnancy increased significantly from 2009 to 2019, with an average annual percent ...

Despite guidelines recommending other anticoagulants for people hospitalized with acute pulmonary embolism (PE), old habits ...

A parallel communication regarding these factors in dogs with experimentally produced pulmonary embolism will be reported elsewhere. 6 All 11 patients in this study were treated on the medical or ...

Breast magnetic resonance imaging (MRI) is an imaging tool that involves contrast agents and powerful magnetic and radio waves to generate highly detailed images of breast tissues. Breast MRIs are ...

Pulmonary Computed Tomography Angiogram (PCTA) Pulmonary computed tomography angiogram (PCTA) is considered the first-choice diagnostic imaging technique when a pulmonary embolism is suspected. PCTA ...

chronic obstructive pulmonary disease (COPD), and patients who have received a lung transplant. Publishing two complementary papers in Radiology and JHLT Open, the team explain how they use a ...